美国 · 平台与数据 · MarketBeat

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

来源：MarketBeat · 美国 1 小时前

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) have received an average rating of "Moderate Buy" from the eighteen ratings firms that are currently…

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

推荐阅读

Prediction: These 3 Stocks Will 10X in the Next 20 Years

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

分享

推荐阅读

Prediction: These 3 Stocks Will 10X in the Next 20 Years

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth